SEC Form 4 · accession 0001140361-15-017410
VASCULAR SOLUTIONS INC · VASC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John L Erb
Director
Period of report
Apr 30, 2015
Accepted (ET)
May 4, 2015 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001030206
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 30, 2015 | F | 1,069 | $32.06 | D | 8,008 | D | |
| Common StockF1 | May 1, 2015 | A | 2,298 | — | A | 10,306 | D | |
| Common Stock | holding | — | — | — | 9,077 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $9.61 | holding | — | — | — | — | Apr 22, 2020 | Common Stock | 10,000 | 10,000 | D |
| Stock Option (Right to Buy)F3 | $11.72 | holding | — | — | — | — | Apr 22, 2021 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1Represents restricted stock award that shall become 100% fully vested on May 1, 2016, subject to continuation of service as a Director of the Company.
- F2100% fully vested.
- F3Vests over 4 years at a rate of 4% on May 22, 2011 and 2% on the 22nd day of each succeeding month; subject to continuation of service as a Director of the Company.